Core Viewpoint - The company Shijiazhuang Pharmaceutical Group has received approval from the National Medical Products Administration of China for two active pharmaceutical ingredients, which are now registered for use in marketed formulations [1] Group 1: Product Approvals - The active pharmaceutical ingredient, isopropyl phenol trimethyl ether, is primarily used to prepare isopropyl phenol injection, which treats acute spasm pain caused by digestive system and biliary dysfunction, acute spasmodic urethral, bladder, and renal colic, as well as gynecological spasmodic pain [1] - The company has obtained the production registration certificate for isopropyl phenol injection from the National Medical Products Administration, as stated in the announcement dated August 27, 2024 [1] Group 2: Additional Product Information - The active pharmaceutical ingredient, hydrochloride dobutamine, is mainly used to prepare hydrochloride dobutamine injection, which is indicated for heart failure caused by decreased myocardial contractility in organic heart disease, including low cardiac output syndrome following cardiac surgery [1]
石四药集团(02005)：间苯三酚三甲醚及盐酸多巴酚丁胺已获国家药监局批准登记成为在上市制剂使用的原料药